237 filings
15-12G
CCXI
ChemoCentryx Inc
31 Oct 22
Securities registration termination
6:06am
S-8 POS
CCXI
ChemoCentryx Inc
20 Oct 22
Registration of securities for employees (post-effective amendment)
9:28am
S-8 POS
CCXI
ChemoCentryx Inc
20 Oct 22
Registration of securities for employees (post-effective amendment)
9:27am
POSASR
CCXI
ChemoCentryx Inc
20 Oct 22
Automatic shelf registration (post-effective amendment)
9:26am
8-K
CCXI
ChemoCentryx Inc
20 Oct 22
Amgen Successfully Completes Acquisition of Chemocentryx
9:20am
25-NSE
ai9fhn2m 01gwvmtqium
20 Oct 22
Exchange delisting
8:40am
8-K
khkmd2bg5ictg
18 Oct 22
Submission of Matters to a Vote of Security Holders
4:16pm
DEFA14A
17acqlrcfg96by 2edij
7 Oct 22
Additional proxy soliciting materials
4:35pm
DEFA14A
w0ye mbxy2xl29j0u
19 Sep 22
Additional proxy soliciting materials
9:26pm
8-K
2klg kxycdbgz6sp
19 Sep 22
Other Events
9:23pm
DEFM14A
bg2sexxrqe38gq6riik
14 Sep 22
Proxy related to merger
5:31pm
PREM14A
aweolugguogukfr
31 Aug 22
Preliminary proxy related to merger
5:07pm
DEFA14A
rknb12o
30 Aug 22
Additional proxy soliciting materials
6:25pm
DEFA14A
kh23gp 16mzcs8b0l
22 Aug 22
Additional proxy soliciting materials
9:28pm
DEFA14A
faa3ihnzw976
9 Aug 22
Additional proxy soliciting materials
12:00am
DEFA14A
53v2fzaz
8 Aug 22
Additional proxy soliciting materials
8:00am
8-K
pt2zv8legg zxi6g5x
4 Aug 22
Amgen to Acquire Chemocentryx for $4 Billion In Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine
8:16am
8-K
rnl70
5 Jul 22
ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director
8:48am
8-K
5pg4a keq
9 Jun 22
Departure of Directors or Certain Officers
4:40pm